Nippon India Pharma Fund - Direct Plan - Bonus Plan

What If You Invested in Nippon India Pharma Fund - Direct Plan - Bonus Plan

1-time
Monthly SIP

₹1L

10L

This Fund's Returns

Profit (Absolute Return)

Fund Name

Expenses

CAGR Returns

Nippon India Pharma Fund - Direct Plan - Bonus Plan

Q: What are the average returns of Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund ?

The return since inception of Nippon India Pharma Fund - Direct Plan - Bonus Plan is 18.48%. The average returns of Nippon India Pharma Fund - Direct Plan - Bonus Plan are Years Returns 1 yr 21.63% 3 yrs 26.82% 5 yrs 16.62%

Q: What is the current NAV of Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund?

The NAV for the fund as on 07-Dec-2021 is 316.9344

Q: How do I invest in Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund?

- Download the INDmoney app - Create your profile - Select any best equity fund from our catalogue - Choose between Starting a SIP or One time lump sum - Complete the payment process

Q: What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Bonus Plan fund?

The expense ratio of this fund is 0.9 %

Q: What is the worth of total assets under management (AUM) of Nippon India Pharma Fund - Direct Plan - Bonus Plan fund ?

The AUM for the fund as on 07-Dec-2021 is 5210 Cr

Q: What are the top holdings of Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund?

The top holdings include Sun Pharmaceuticals Industries Ltd 11.6% Dr Reddy's Laboratories Ltd 9.39% Divi's Laboratories Ltd 7.91% Cipla Ltd 7.82% Aurobindo Pharma Ltd 7.28%

Q: What are the top sectors Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund has invested in?

The fund has majorly invested in Cash Equivalent 100% Health 100%

Equity

Direct

Very High Risk

Sector - Healthcare

NAV: ₹ 316.9 as on 06-12-2021

About the Fund

Nippon India Pharma Fund - Direct Plan - Bonus Plan is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Sailesh Raj Bhan, Kinjal Desai. The fund could potentially beat inflation in the long-run.

Key parameters

1) Nippon India Pharma Fund - Direct Plan - Bonus Plan has a NAV of 316.9344 as on 07-Dec-2021.

2) Nippon India Pharma Fund - Direct Plan - Bonus Plan has 5210 Cr worth of assets under management (AUM) as on 07-Dec-2021 and is more than category average.

3) The fund has an expense ratio 0.9 %.

Fund Overview

Expense ratio	0.9%
	Benchmark	S&P BSE Healthcare PR
AUM	₹5210 Cr
Inception Date	1 January, 2013
Min Lumpsum/SIP	₹5000/₹0
	Exit Load	1%
Lock In	No Lock-in
	TurnOver	55.36%

Fund Distribution

Equity 95.4%
Debt & Cash 4.6%

Size breakup

Large cap

76.79%

Mid cap

14.06%

Small cap

8.35%

Micro cap

0.8%

Sector Allocation

Top Holdings

All
Equity
Debt & Cash

Total Holdings20

Equity Holdings20

Debt Holdings3

Sun Pharmaceuticals Industries Ltd	11.6%
Dr Reddy's Laboratories Ltd	9.4%
Divi's Laboratories Ltd	7.9%
Cipla Ltd	7.8%
Aurobindo Pharma Ltd	7.3%
Apollo Hospitals Enterprise Ltd	6.6%
Lupin Ltd	5.5%
Abbott India Ltd	5%

See all

Fund Highlights

About the fund

This fund has delivered an average annual returns of 18.5% since inception which is less than its category average return of 29.07%

Fund Allocations

This fund has an allocation of 95.4% in Equity, 0% in Debt and 4.6% in Cash related instruments

AUM size ₹5210 Cr

This fund has AUM of ₹5210 Cr which is more than its category average of ₹ 1548 Cr

Expense Ratio 0.9%

This fund has an expense ratio of 0.9% which is less than its category average expense ratio of 1.55%

AMC details

Fund House

Nippon Life India Asset Management Ltd

customer_care@reliancemutual.com

Phone

+912230994600/30301111

Address

Reliance Capital Asset Management Ltd.,One India Bulls Centre - Tower One,,11th & 12th floor, Jupiter Mills Compound,,Elphinstone Road,

Similar Funds

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl

₹17.15

24.06% (3 Yrs)

SBI Healthcare Opportunities Fund Direct Payout Inc Dist cum Cap Wdrl

₹167.06

24.22% (3 Yrs)

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Reinvmt of Inc Dist cum Cap Wdrl

₹17.15

24.06% (3 Yrs)

Mirae Asset Healthcare Fund Direct Payout of Income Distribution cum capital withdrawal

₹23.82

32.72% (3 Yrs)

SBI Healthcare Opportunities Fund Direct Reinvestment Inc Dist cum Cap Wdrl

₹167.06

24.22% (3 Yrs)

Frequently Asked Questions

What are the average returns of Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund ?

What is the current NAV of Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund?

How do I invest in Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund?

What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Bonus Plan fund?

What is the worth of total assets under management (AUM) of Nippon India Pharma Fund - Direct Plan - Bonus Plan fund ?

What are the top holdings of Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund?

What are the top sectors Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund has invested in?

Markets:

Stocks:

Best Mutual Funds:

Mutual Funds:

US Stocks:

US Stocks Guide:

Bonds:

Tools:

Explore AMCs:

INDmoney, INDwealth, IND.app, IND.money, INDsave.com are brand and product of Finzoom Investment Advisors (P) Limited.

Finzoomers Services Private Limited - [Registered address: 624-625, 6th Floor, Suncity Success Tower, Golf Course Extension Road, Sector - 65 Gurugram – HR- 122005] [IRDAI Corporate Agent (Composite) Registration No- CA0744 Validity till - 02/03/2024] [Principal Officer- Mr. Ankur Goyal, Principal Officer email id- po@finzoomers.in] [CIN: U74990HR2020PTC086201] [GST No: 06AAECF0692E1ZV] [Email id: insurancesupport@indmoney.com]

Finzoom Investment Advisors Private Limited makes no warranties or representations, express or implied, on products and services offered through the platform. It accepts no liability for any damages or losses, however, caused in connection with the use of, or on the reliance of its advisory or related services.

Past performance is not indicative of future returns. Please consider your specific investment requirements, risk tolerance, goal, time frame, risk and reward balance and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs. Performance and returns of any investment portfolio can neither be predicted nor guaranteed.

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.

Marketing and distribution of various financial products such as loans, deposits and Insurance are powered by Finzoomers Services Private Limited.

[SEBI RIA Registration No: INA100012190] [Type of Registration: Non-Individual] [Validity of registration: December 17, 2018-Perpetual] [Address: 616, 6th Floor, Suncity Success Tower, Golf Course Extension Road, Sector – 65, Gurugram, Haryana- 122005] [Corresponding SEBI local office address: Securities and Exchange Board of India, Local Office, First Floor, SCO 127-128, Sector 17C, Chandigarh-160017][Principal Officer details: Mr. Gaurav Sharma, Email id: principalofficer@indmoney.com]

[ARN - 151913] [Platform Partner : BSE (Member code-24801)] [CIN - U67190HR2018PTC073294] [GST No : 06AADCF3538Q1Z8]

US stocks watchlist

Mutual Funds watchlist

Nippon India Pharma Fund - Direct Plan - Bonus Plan

NAV: ₹ 316.9 as on 06-12-2021

Fund Overview

Fund Distribution

Top Holdings

Fund Highlights

Fund Manager

About the fund

Fund Allocations

AUM size ₹5210 Cr

Expense Ratio 0.9%

AMC details

Similar Funds

What are the average returns of Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund ?

What is the current NAV of Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund?

How do I invest in Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund?

What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Bonus Plan fund?

What is the worth of total assets under management (AUM) of Nippon India Pharma Fund - Direct Plan - Bonus Plan fund ?

What are the top holdings of Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund?

What are the top sectors Nippon India Pharma Fund - Direct Plan - Bonus Plan Fund has invested in?